WhitTier Trust Company’s Acorda Therapeutics ACOR Stock Holding History

WhitTier Trust Company’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12	Closed	-$35K	–	1013
2017 Q3	$35K	Hold	12	–	–	﹤0.01%	610
2017 Q2	$27K	Buy	12 +7	+140%	+$13.9K	﹤0.01%	648
2017 Q1	$14K	Hold	5	–	–	﹤0.01%	729
2016 Q4	$12K	Hold	5	–	–	﹤0.01%	751
2016 Q3	$14K	Hold	5	–	–	﹤0.01%	734
2016 Q2	$17K	Hold	5	–	–	﹤0.01%	709
2016 Q1	$17K	Hold	5	–	–	﹤0.01%	709
2015 Q4	$28K	Hold	5	–	–	﹤0.01%	621
2015 Q3	$17K	Hold	5	–	–	﹤0.01%	713
2015 Q2	$22K	Hold	5	–	–	﹤0.01%	692
2015 Q1	$22K	Hold	5	–	–	﹤0.01%	691
2014 Q4	$27K	Hold	5	–	–	﹤0.01%	646
2014 Q3	$22K	Hold	5	–	–	﹤0.01%	689
2014 Q2	$22K	Hold	5	–	–	﹤0.01%	703
2014 Q1	$25K	Hold	5	–	–	﹤0.01%	685
2013 Q4	$19K	Hold	5	–	–	﹤0.01%	700
2013 Q3	$22K	Hold	5	–	–	﹤0.01%	646
2013 Q2	$22K	Buy	+5	New	+$20.6K	﹤0.01%	624

Other funds holding ACOR

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WhitTier Trust Company's ACOR Position: Q4 2017 in Review

WhitTier Trust Company sold out of Acorda Therapeutics (ACOR) in Q4 2017, closing a stake of 12 shares — an estimated $35K sold.

WhitTier Trust Company first reported a position in ACOR in Q2 2013 and held it in 18 quarters. The position peaked at $35K in Q3 2017. 150 funds tracked by Wall St. Rank hold ACOR as of Q4 2017.

WhitTier Trust Company reported no remaining Acorda Therapeutics position as of Q4 2017 after selling out during the quarter.
WhitTier Trust Company sold 12 Acorda Therapeutics shares in Q4 2017, an estimated $35K.
WhitTier Trust Company first reported a position in Acorda Therapeutics in Q2 2013 and held it in 18 quarters.
WhitTier Trust Company's Acorda Therapeutics position peaked at $35K in Q3 2017.
150 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2017.

Based on WhitTier Trust Company's 13F filing for Q4 2017, filed 7 Feb 2018.